Stock Forecast
As of Sat Feb 20 2021 00:00:02 GMT+0000 (Coordinated Universal Time) shares of EIGR Eiger BioPharmaceuticals 3.38 percentage change in price since the previous day's close. Around 141544 of 32532000 changed hand on the market. The Stock opened at 11.28 with high and low of 11.28 and 11.86 respectively. The price/earnings ratio is: - and earning per share is -2.44. The stock quoted a 52 week high and low of 4.55 and 13.99 respectively.
BOSTON (AI Forecast Terminal) Sat, Feb 20, '21 AI Forecast today took the forecast actions: In the context of stock price realization of EIGR Eiger BioPharmaceuticals is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+1y) for EIGR Eiger BioPharmaceuticals as below:
EIGR Eiger BioPharmaceuticals Credit Rating Overview
We rerate EIGR Eiger BioPharmaceuticals because of adding the amount of unrecognized gains, after tax, when calculating ACE and TAC. Nevertheless, the adjustment for unrecognized gains would be reduced by the amount of the surplus that we view as unrealizable. We use econometric methods for period (n+1y) simulate with Pierce Oscillators Linear Regression. Reference code is: 4982. Beta DRL value REG 44 Rational Demand Factor LD 6177.3516. Our liquidity uses include dividends and share repurchases that we expect under a stress scenario. Unlike other potential uses of liquidity, such as debt maturities or maintenance capital spending, we view dividends and share repurchases as more discretionary, although more so for the latter. For this reason, when evaluating a company's liquidity position, we may use a lower estimate of dividends and shareholder repurchases than in our base-case forecast based on our views of management and the company's track record in terms of shareholder returns and maintaining a certain minimum level of liquidity. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.
Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for EIGR Eiger BioPharmaceuticals as below:
Frequently Asked Questions
Q: What is EIGR Eiger BioPharmaceuticals stock symbol?A: EIGR Eiger BioPharmaceuticals stock referred as NASDAQ:EIGR
Q: What is EIGR Eiger BioPharmaceuticals stock price?
A: On share of EIGR Eiger BioPharmaceuticals stock can currently be purchased for approximately 11.63
Q: Do analysts recommend investors buy shares of EIGR Eiger BioPharmaceuticals ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for EIGR Eiger BioPharmaceuticals at daily forecast section
Q: What is the earning per share of EIGR Eiger BioPharmaceuticals ?
A: The earning per share of EIGR Eiger BioPharmaceuticals is -2.44
Q: What is the market capitalization of EIGR Eiger BioPharmaceuticals ?
A: The market capitalization of EIGR Eiger BioPharmaceuticals is 378347163
